Anafranil
Clomipramine Hydrochloride
Sourced from the FDA Orange Book
Key dates
Key dates
Approval
FDA approval date of this drug product.
Dec 29, 1989
37 yr 1 mo ago
Today
Pharmaceutical detail
Pharmaceutical detail
Active ingredient
CLOMIPRAMINE HYDROCHLORIDE
Strength
50MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 019906
Product number
002
Marketing status
Prescription
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Other strengths in NDA 019906
Active-ingredient family
This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023Clomipramine HydrochlorideGeneric (ANDA)
ANDA 216440 · Aurobindo Pharma
- 2021Clomipramine HydrochlorideGeneric (ANDA)
ANDA 211822 · Alembic
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 213897 · Ajanta Pharma Ltd
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 212285 · Unique
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 213219 · Micro Labs
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 213221 · Rk Pharma
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 210653 · Tp Anda Holdings
- 2020Clomipramine HydrochlorideGeneric (ANDA)
ANDA 211364 · Ixora Lifescience
- 2019Clomipramine HydrochlorideGeneric (ANDA)
ANDA 212218 · Jubilant Cadista
- 2019Clomipramine HydrochlorideGeneric (ANDA)
ANDA 211767 · Mankind Pharma
- 2018Clomipramine HydrochlorideGeneric (ANDA)
ANDA 209294 · Lupin
- 2018Clomipramine HydrochlorideGeneric (ANDA)
ANDA 208632 · Amneal Pharms Co
Listed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Anafranil — frequently asked questions
Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.
Built directly from the FDA Orange Book data file. This product page links back to the Clomipramine Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

